Franklin Resources’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.6M | Buy |
4,097,625
+79,255
| +2% | +$515K | 0.01% | 837 |
|
|
2025
Q1 | $31.9M | Buy |
4,018,370
+135,418
| +3% | +$1.07M | 0.01% | 751 |
|
|
2024
Q4 | $49.2M | Buy |
3,882,952
+13,320
| +0.3% | +$169K | 0.01% | 621 |
|
|
2024
Q3 | $55.3M | Buy |
3,869,632
+87,262
| +2% | +$1.25M | 0.02% | 564 |
|
|
2024
Q2 | $52.1M | Sell |
3,782,370
-24,420
| -0.6% | -$337K | 0.02% | 542 |
|
|
2024
Q1 | $62.9M | Sell |
3,806,790
-430,005
| -10% | -$7.1M | 0.02% | 502 |
|
|
2023
Q4 | $61.9M | Buy |
4,236,795
+169,463
| +4% | +$2.47M | 0.03% | 443 |
|
|
2023
Q3 | $49.9M | Buy |
4,067,332
+1,664
| +0% | +$20.4K | 0.03% | 494 |
|
|
2023
Q2 | $48.5M | Buy |
4,065,668
+658,797
| +19% | +$7.87M | 0.02% | 529 |
|
|
2023
Q1 | $45.5M | Buy |
3,406,871
+934,022
| +38% | +$12.5M | 0.02% | 547 |
|
|
2022
Q4 | $53.2M | Sell |
2,472,849
-3,857
| -0.2% | -$83K | 0.03% | 511 |
|
|
2022
Q3 | $49.6M | Buy |
2,476,706
+11,326
| +0.5% | +$227K | 0.03% | 525 |
|
|
2022
Q2 | $44.1M | Buy |
2,465,380
+922,521
| +60% | +$16.5M | 0.02% | 578 |
|
|
2022
Q1 | $15.3M | Buy |
1,542,859
+581,633
| +61% | +$5.77M | 0.01% | 918 |
|
|
2021
Q4 | $16.2M | Buy |
961,226
+370,699
| +63% | +$6.25M | 0.01% | 944 |
|
|
2021
Q3 | $14M | Buy |
590,527
+71,561
| +14% | +$1.7M | 0.01% | 973 |
|
|
2021
Q2 | $11.8M | Buy |
+518,966
| New | +$11.8M | ﹤0.01% | 982 |
|